Healthy Skepticism Library item: 11753
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
Publication type: Journal Article
Riddle MA.
Commentary by an academic child and adolescent psychiatrist.
J Child Adolesc Psychopharmacol 2007 Jun; 17:(3):300-2
http://www.liebertonline.com/doi/abs/10.1089/cap.2007.0001
Abstract:
The interests of children and adolescents with psychiatric disorders would best be served if academic child and adolescent psychiatrists, academic medical institutions, prescribing clinicians, child and family advocates, the National Institutes of Health (NIH), the Food and Drug Administration, and the pharmaceutical industry partnered to maximize the development and dissemination of safe and effective psychiatric medications. Before this critical goal can be achieved, however, each partner must demonstrate commitment, not only to its own core missions, but also to working to eliminate overt and covert conflicts of interest that can diminish professional integrity, public trust, and patient safety. This commentary focuses on identifying major barriers to reaching these goals, and on the role that academic child and adolescent psychiatrists can play in reducing them…
Keywords:
Publication Types:
Review
MeSH Terms:
Academic Medical Centers*
Drug Industry*
Humans
Interinstitutional Relations*
Pediatrics/organization & administration*
Physician's Role
Psychiatry/organization & administration*
United States
United States Food and Drug Administration
Notes:
Free full text
